In Vitro Activity of Ceftolozane-Tazobactam against Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa Obtained from Blood Cultures from Sentinel Public Hospitals in South Africa

Multidrug-resistant (MDR) Gram-negative bacteria are responsible for the majority of healthcare-associated infections and pose a serious threat as they complicate and prolong clinical care. A novel cephalosporin-β-lactamase-inhibitor combination, ceftolozane-tazobactam (C/T) was introduced in 2014,...

Descripción completa

Detalles Bibliográficos
Autores principales: Perovic, Olga, Singh-Moodley, Ashika, Lowe, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044232/
https://www.ncbi.nlm.nih.gov/pubmed/36978322
http://dx.doi.org/10.3390/antibiotics12030453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044232/
https://www.ncbi.nlm.nih.gov/pubmed/36978322
http://dx.doi.org/10.3390/antibiotics12030453

Ejemplares similares